NeoGenomics Prices $275 Million Convertible Senior Notes Offering, Announces Strategic Capital Structure Moves NeoGenomics, a leading oncology diagnostics company focused on enabling precision medicine through advanced testing solutions, has announced…
Redcare Pharmacy Accelerates Growth Momentum, Expands Profitability and Raises Full-Year 2026 Guidance Redcare Pharmacy has reported stronger-than-anticipated trading performance during the first two months of the second quarter of 2026,…
Florida Budget Deal Restores HIV Drug Assistance Program, Reversing Controversial Cuts Thousands of Floridians living with HIV are set to regain access to critical healthcare services after state lawmakers reached…
HealthNet and AndHealth Open New Pharmacy in Indianapolis to Expand Affordable Medication Access and Integrated Specialty Care HealthNet and AndHealth have officially opened the new HealthNet Pharmacy at the Barrington…
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs…
U.S. Pushes for Radiopharmaceutical Independence as Demand Surges As global demand for radiopharmaceuticals and nuclear medicine continues to accelerate, U.S.-based manufacturers are stepping up efforts to expand domestic production capacity…
SingleCell Biotechnology Unveils High-Throughput Single-Cell Assay Linking Clonal Growth to Molecular Profiles at AACR Single-cell analysis is rapidly reshaping how researchers understand cancer, particularly in the context of tumor heterogeneity…
GNQ Insilico and IBM Collaborate to Advance Precision Medicine and Clinical AI Adoption In a significant move aimed at transforming the future of healthcare and drug development, GNQ Insilico has…
Blaine Labs Issues Voluntary Nationwide Recall of Wound Care Gel Products Due to Microbial Contamination Blaine Labs, Inc., a healthcare products manufacturer based in Santa Fe Springs, California, has announced…
Vyome to Present Full Phase 2 Clinical Data on VT-1953 for Malignant Fungating Wounds at AACR 2026 Vyome Holdings, Inc. , a clinical-stage biopharmaceutical company focused on developing novel therapies…
PureTech Founded Entity Seaport Therapeutics Publishes First-in-Human Data on GlyphAllo™ (SPT-300) in Science Translational Medicine PureTech Health plc a biotherapeutics company focused on advancing innovative science into impactful medicines, announced…
FDA Accepts Application Covering 64 SKUs, Moving Sesh Closer to Potential Marketing Authorization Sesh Products US, Inc. has announced a significant regulatory milestone in its efforts to bring its nicotine…